Monopar Therapeutics Inc.
MNPR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$16 | -$8 | -$11 | -$9 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1 | $2 | $2 | $1 |
| Change in WC | $3 | -$1 | $2 | $0 |
| Other Non-Cash | $5 | $0 | $0 | $0 |
| Operating Cash Flow | -$6 | -$8 | -$7 | -$7 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$15 | -$8 | -$5 | $0 |
| Inv. Sales/Matur. | $1 | $13 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$14 | $5 | -$5 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $59 | $2 | $0 | $11 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | -$0 | -$0 | -$0 |
| Financing Cash Flow | $59 | $2 | $0 | $11 |
| Forex Effect | $0 | -$0 | -$0 | $0 |
| Net Chg. in Cash | $39 | -$1 | -$12 | $4 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $7 | $8 | $20 | $17 |
| End Cash | $46 | $7 | $8 | $20 |
| Free Cash Flow | -$6 | -$8 | -$7 | -$7 |